Analyses of HIV Integration Components

  • Kathryn S. Jones
  • Joseph Kulkosky
  • Anna Marie Skalka
Part of the GWUMC Department of Biochemistry Annual Spring Symposia book series (GWUN)

Abstract

The single-stranded genomic RNA of retroviruses is reverse-transcribed to produce double-stranded linear DNA shortly after entry of the virion into the host cell. For HIV, this reaction has provided the first effective target for anti-viral therapy. Following reverse transcription, viral DNA is stably integrated into the host cell genome. The study of integration is important since this event appears to be obligatory for efficient replication of all retroviruses including HIV and, as with reverse transcription, this reaction has no obvious cellular counterpart. Thus, the integration reaction represents another attractive target for the development of specific inhibitors. Although the requirements for efficient integration of HIV DNA have not yet been thoroughly defined, general features can be inferred from studies with more simple retroviruses, such as the avian sarcoma/leukosis (ASLV) and murine leukemia (MLV) viruses. For these viruses, integration is dependent upon 1) cis-acting sequences at the ends of the linear viral DNA and 2) activities of the integration protein (IN) encoded in the 3′ portion of the retroviral pol gene (Skalka, 1988; Varmus and Brown, 1989; Kulkosky and Skalka, 1990). Recent studies from our laboratory have demonstrated that the ASLV IN is, in fact, both necessary and sufficient to direct integrative recombination in vitro (Katz et al., 1990).

Keywords

Leukemia Recombination Electrophoresis Polypeptide Paraformaldehyde 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cochrane, A. W., Perkins, A., and Rosen, C., 1990, Identification of sequences important in the nucleolar localization of human immunodeficiency virus rev: Relevance of nucleolar localization to function, J. Virol., 64: 881.PubMedGoogle Scholar
  2. Dayton, A. I., Terwillinger, E. F., Potz, J., Kowalski, M., Sodroski, J. G., and Haseltine, W. A., 1988, Cis-acting sequences responsive to the rev gene product of the human immunodeficiency virus, JAIDS 1: 441.Google Scholar
  3. Emerman, M., Vazeux, R., and Peden, K., 1989, The rev gene product of human immunodeficiency virus affects envelope-specific RNA localization, Cell 57: 1155.PubMedCrossRefGoogle Scholar
  4. Hadzopoulou-Cladaras, M., Felber, B. K., Cladaras, C., Athanassopoulos, A., Tse, A., and Pavlakis, G. N., 1989, The rev (trs/art) protein of human immunodeficiency virus type I affects viral mRNA and protein expression via a cis-acting sequence in the env regions, J. Virol. 63: 1265.PubMedGoogle Scholar
  5. Huber, H. E., and Richardson, C. C., Processing of the primer for plus strand DNA synthesis by human immunodeficiency virus 1 reverse transcriptase, J. Biol. Chem. 265: 10565.Google Scholar
  6. Jones, K.S., and Skalka, A.M., HIV integration protein: Independent expression and subcellular location in eukaryotic cells. Submitted for publication.Google Scholar
  7. Hammarskjöld, M.-L., Heimer, J., Hammarskjöld, B., Sangwan, I., Albert, L., and Rekosh, D., 1989, Regulation of human immunodeficiency virus env expression by the rev gene product, J. Virol. 63: 1959.PubMedGoogle Scholar
  8. Katz, R. A., Merkel, G., Kulkosky, J., Leis, J. and Skalka, A. M., 1990, The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro,Cell, in press.Google Scholar
  9. Kulkosky, J., Katz, R., and Skalka, A. M., 1990, Terminal nucleotides of the preintegrative linear form of HIV-1 DNA deduced from the sequence of circular DNA junctions, JAIDS, 3: 852.Google Scholar
  10. Kulkosky, J., and Skalka, A. M., 1990, HIV DNA integration: Observations and inferences, JAIDS, 3: 839.Google Scholar
  11. Malim, M. H., Hauber, J., Le, S.-Y., Maizel, J. V., and Cullen, B. R., 1989, The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA, Nature 338: 254.PubMedCrossRefGoogle Scholar
  12. Morris-Vasios, C., Kochan, J. P., and Skalka, A. M., 1988, Avian sarcoma-leukosis virus reol-endo proteins expressed independently in mammalian cells accumulate in the nucleus but can be directed to other cellular components, J. Viral. 62: 349.Google Scholar
  13. Rosen, C. A., Terwilliger, E., Dayton, A., Sodroski, J. G., and Haseltine, W. A., 1988, Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus, Proc. Natl. Acad. Sci. USA 85: 2071.PubMedCrossRefGoogle Scholar
  14. Skalka, A. M., 1988, Integrative recombination of retroviral DNA, in: “Genetic Recombination,” R. Kuperlapati, and G. R. Smith, eds., American Society for Microbiology, Washington, DC.Google Scholar
  15. Sodroski, J., Goh, W. C., Rosen, C., Dayton, A., Terwilliger, E., and Haseltine, W., 1986, A second post-transcriptional transactivator gene required for HTLV-III replication, Nature (London) 321: 412.Google Scholar
  16. Terwilliger, E., Burghoff, R., Sia, R., Sodroski, J., Haseltine, W., and Rosen, C., 1988. The rev gene product of human immunodeficiency virus is required for replication, J. Virol. 62: 655.PubMedGoogle Scholar
  17. Varmus, H., and Brown, P., 1989, Retroviruses, in: “Mobile DNA,” D. Berg, and M. Howe, eds., American Society for Microbiology, Washington, DC.Google Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Kathryn S. Jones
    • 1
  • Joseph Kulkosky
    • 1
  • Anna Marie Skalka
    • 1
  1. 1.Institute for Cancer ResearchFox Chase Cancer CenterPhiladelphiaUSA

Personalised recommendations